Biogen names EVP, pharmaceutical operations & technology
Dr. McKenzie was promoted from his previous position as senior vice president of Global Biologics Manufacturing and Technical Operations.
Dr. McKenzie joined Biogen in February from Johnson & Johnson, where he held a variety of leadership roles, most recently as vice president of R&D for J&J’s Ethicon business.
Prior to that role, Dr. McKenzie led the manufacturing and technical operations team responsible for internal and external manufacturing of Janssen’s pharmaceutical portfolio.
He also ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical development and commercialization.
Dr. McKenzie also held various R&D and manufacturing positions at Bristol-Myers Squibb and Merck.
Dr. McKenzie graduated from the University of Pennsylvania and received his doctorate in chemical engineering from Carnegie Mellon University.
He replaces John Cox, who last month was named chief executive officer of a new Biogen spin-off company dedicated to advancing treatments for hemophilia. ■
What to read next
LATEST MOVES FROM Massachusetts
- DentaQuest appoints Alison Corcoran as CMO
- RXI Pharma names Gerrit Dispersyn chief development officer
- resTORbio appoints Joan Mannick as CMO
- C&W Services appoints Mike Losier as director
- Charles River Associates appoints Robert A. Whitman to board
More inside POST
Monsanto Q2 EPS reached $3.09 Earnings